Nicotinamide supplementation in diabetic nonalcoholic fatty liver disease patients: randomized controlled trial

• Autores principales: Rasha R. El-Kady (Autor), Amani K. Ali (Autor), Lamia M. El Wakeel (Autor), Nagwa A. Sabri (Autor), May A. Shawki (Autor)
• Formato: Libro
• Publicado: SAGE Publishing, 2022-02-01T00:00:00Z.
• Materias: article
• Acceso en línea: Connect to this object online.

Background: Nicotinamide has been reported to protect against liver steatosis and metabolic imbalances in nonalcoholic fatty liver disease (NAFLD) in animal models. Objectives: The objective was to investigate the efficacy and safety of nicotinamide supplementation in diabetic NAFLD patients. Design...